Indian companies get USFDA nod for 14 1st-time generic drugs in 2015 - Feedback

Indian pharma firms accounted for 14 of total 90 first-time generic drug approvals granted by the United States Food and Drug Administration in 2015.

Major domestic firms such as Sun Pharma , Lupin , Glenmark, Aurobindo , Alembic and Hetero Labs figure in the list of first-time generic drug approvals released by the FDA’s Office of Generic Drugs. The approvals include Sun Pharma’s Imatinib Mesylate tablets used for treatment of cancer and Lupin’s Repaglinde and Metformin Hydrochloride tablets among others. As per the list, Glenmark received approval for Ezetimibe tablets that are generic of lipid lowering Zetia tablets.

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *